Financial statements Bio - Med
Balance sheet data of BIO - MED
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 10 074 323,20 | 14 933 326,43 | 15 835 228,75 | 14 587 610,82 | 17 281 878,49 | 19 488 358,90 |
| A. Fixed assets | 6 663 090,02 | 7 269 412,00 | 7 021 126,38 | 10 967 907,76 | 13 382 872,66 | 14 998 106,43 |
| B. Current assets | 3 411 233,18 | 7 663 914,43 | 8 814 102,37 | 3 619 703,06 | 3 899 005,83 | 4 490 252,47 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 10 074 323,20 | 14 933 326,43 | 15 835 228,75 | 14 587 610,82 | 17 281 878,49 | 19 488 358,90 |
| A. Equity | 5 593 977,43 | 8 653 191,29 | 11 032 848,27 | 11 615 074,25 | 11 847 180,68 | 11 587 184,33 |
| B. Liabilities and provisions for liabilities | 4 480 345,77 | 6 280 135,14 | 4 802 380,48 | 2 972 536,57 | 5 434 697,81 | 7 901 174,57 |
| I. Long-term liabilities | 556 368,40 | 716 519,51 | 573 279,26 | 230 036,10 | 695 610,83 | 554 376,25 |
| II. Short-term liabilities | 2 985 609,25 | 4 796 368,59 | 3 654 132,52 | 2 307 315,65 | 4 204 401,12 | 5 918 469,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.